|
|
|
|
potential drugs for treating covid-19 infection
|
|
|
|
|
|
|
|
نویسنده
|
mohammadi mehrdad ,sandle tim ,rajabi sajad ,khorshidi ahmad ,piroozmand ahmad
|
|
منبع
|
international journal of infection - 2020 - دوره : 7 - شماره : 4 - صفحه:1 -10
|
|
چکیده
|
The novel coronavirus disease 2019 (covid-19) appeared as an emerging respiratory disease in december 2019 in wuhan, hubei province, china, and then spread rapidly worldwide, being declared a pandemic on march 11, 2020. researchers are attempting to discover specifically designed antiviral treatments for covid-19. several therapeutic agents such as interferon-α, lopinavir/ritonavir, ribavirin, chloroquine, chloroquine phosphate, hydroxychloroquine, arbidol, favipiravir, remdesivir, darunavir, imatinib, teicoplanin, azithromycin, covid-19 convalescent plasma, other potential antiviral drugs, and chinese herbal agents are now being clinically studied to examine both pharmaceutical efficacy and safety for covid-19 treatment in several countries. some favorable results from these studies have been obtained to date. this review article summarizes and reiterates drugs that are potentially efficient against covid-19.
|
|
کلیدواژه
|
novel coronavirus ,covid-19 ,antiviral drug ,treatment
|
|
آدرس
|
kashan university of medical sciences, faculty of medicine, department of microbiology and immunology, iran, bio products laboratory, uk, iran university of medical sciences, school of medicine, department of gynecology and obstetrics, iran, kashan university of medical sciences, faculty of medicine, department of microbiology and immunology, iran, kashan university of medical sciences, school of medicine, department of microbiology and immunology, iran
|
|
پست الکترونیکی
|
apiroozmand@kaums.ac.ir
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|